| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/08/2004 | CA2491034A1 Methods and materials for treating human papillomavirus infections |
| 01/08/2004 | CA2490781A1 Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof |
| 01/08/2004 | CA2490766A1 A system and method for snp genotype clustering |
| 01/08/2004 | CA2490765A1 Nano-sized optical fluorescence labels and uses thereof |
| 01/08/2004 | CA2490548A1 Genes encoding proteins with pesticidal activity |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490348A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | CA2490290A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | CA2490283A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | CA2490274A1 Use of regulatory sequences in transgenic plants |
| 01/08/2004 | CA2490256A1 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | CA2490017A1 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 01/08/2004 | CA2489520A1 A method for the detection of apoptosis |
| 01/08/2004 | CA2488853A1 Process and materials for production of glucosamine and n-acetylglucosamine |
| 01/08/2004 | CA2488616A1 Isolation of nucleic acids using a polycationic polymer as precipitation agent |
| 01/08/2004 | CA2486543A1 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/08/2004 | CA2486538A1 Pain signaling molecules |
| 01/08/2004 | CA2486116A1 Tagetes erecta marigolds with altered carotenoid compositions and ratios |
| 01/08/2004 | CA2392863A1 A high capacity recombinant adenoviral vector for treatment of hemophilia a |
| 01/07/2004 | EP1378576A1 Storing and detecting nucleic acid administered to a solid carrier |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378571A1 5' ESTs for secreted proteins expressed in various tissues |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378569A1 Method of extracting virus gene and extraction apparatus |
| 01/07/2004 | EP1378567A1 Bacterial adpglucose pyrophosphatase, method for obtaining the latter and its use in the production of assay devices and in the obtention of transgenic plants and bacteria |
| 01/07/2004 | EP1378566A2 Modified reductase from Penicillium citrinum and its encoding gene |
| 01/07/2004 | EP1378525A2 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1378520A1 Cyclic single strand trispecific antibody |
| 01/07/2004 | EP1378516A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for HIV |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377901A2 Method for the evolutionary design of biochemical reaction networks |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377828A2 Methods of analysis and labeling of protein-protein interactions |
| 01/07/2004 | EP1377684A1 Methods for identifying small molecules that bind specific rna structural motifs |
| 01/07/2004 | EP1377682A1 Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotides |
| 01/07/2004 | EP1377681A2 Method of separating alleles |
| 01/07/2004 | EP1377680A2 Diagnosis and treatment of cancer: i |
| 01/07/2004 | EP1377679A2 Method and kit for enhancing the association rates of polynucleotides |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377673A2 Glycosilated cationic lipids for liposomes used in drug delivery |
| 01/07/2004 | EP1377672A2 Vector constructs |
| 01/07/2004 | EP1377671A2 Oncolytic adenoviral vectors |
| 01/07/2004 | EP1377670A1 Transgenic plants with reduced adenylate kinase activity showing an increased accumulation of starch |
| 01/07/2004 | EP1377669A2 Production of apomictic seed |
| 01/07/2004 | EP1377668A2 Artificial chromosomes comprising ehv sequences |
| 01/07/2004 | EP1377666A2 Plant growth regulating genes, proteins and uses thereof |
| 01/07/2004 | EP1377665A2 Final segregation of male meiotic products in plants |
| 01/07/2004 | EP1377664A2 Genes encoding proteolytic enzymes from aspargilli |
| 01/07/2004 | EP1377663A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 01/07/2004 | EP1377662A2 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa) |
| 01/07/2004 | EP1377660A2 Vaccine against the nile fever virus |
| 01/07/2004 | EP1377611A2 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 01/07/2004 | EP1377610A2 Osteoprotegerin in milk |
| 01/07/2004 | EP1377608A1 Insulin precursors and a process for their preparation |
| 01/07/2004 | EP1377607A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid |
| 01/07/2004 | EP1377605A2 Secreted streptococcus pneumoniae proteins |
| 01/07/2004 | EP1377604A2 Methods and means for use of hla-dq restricted t-cell receptors and hla-dq-binding prolamine-derived peptides |
| 01/07/2004 | EP1377603A1 Protein cluster v |
| 01/07/2004 | EP1377598A2 Carotenoid biosynthesis |
| 01/07/2004 | EP1377596A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 01/07/2004 | EP1377595A2 Antisense modulation of histone deacetylase 1 expression |
| 01/07/2004 | EP1377369A2 Substrates, preparation and use |
| 01/07/2004 | EP1377320A2 Polynucleotide binding complexes comprising sterols and saponins |
| 01/07/2004 | EP1377319A2 Fusion proteins |
| 01/07/2004 | EP1377314A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377305A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/07/2004 | EP1377213A1 Method of predicting stroke evolution utilising mri |
| 01/07/2004 | EP1377165A2 Tsg101-gag interaction and use thereof |
| 01/07/2004 | EP1377157A2 Novel pesticidal toxins |
| 01/07/2004 | EP1377156A1 Method of enhancing entomophilous |
| 01/07/2004 | EP1230354B1 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 01/07/2004 | EP1034187B1 Growth-promoting proteins and peptides for kidney epithelial cells |
| 01/07/2004 | EP1028741B1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 01/07/2004 | EP1019082B1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/07/2004 | EP0931092B1 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 01/07/2004 | EP0722500B1 Genes for butyrobetaine/crotonobetaine-l-carnitine metabolism and their use for the microbiological production of l-carine |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | EP0551386B1 Methods for treating cotton-containing fabrics with cellulase |
| 01/07/2004 | CN1466682A HCV antigen/antibody combination assay |
| 01/07/2004 | CN1466630A Fermentation process for the preparation of L-amino acids using strains of the family enterobacteriaceae |
| 01/07/2004 | CN1466629A Modulation of abscisic acid signal transduction in plants |
| 01/07/2004 | CN1466628A A method of extracellular production of target proteins employing OmpF in e coli |
| 01/07/2004 | CN1466626A Production process of subtilin surfactin |
| 01/07/2004 | CN1466625A Method of proliferating natural killer cells |
| 01/07/2004 | CN1466466A Remedies for heart failure |
| 01/07/2004 | CN1465717A Determination for specificity of one segmentum gonococcus DNA sequence (4) and use thereof |
| 01/07/2004 | CN1465703A Synthesis, expression, preparation and application for human parathyroid hormone gene mutant |
| 01/07/2004 | CN1465702A Purifying and use for human vascular endothelial growth factor and granzyme B fusion protein |
| 01/07/2004 | CN1465701A Novel ribozyme of specificity cutting survivin, its medicinal composition and use |
| 01/07/2004 | CN1465700A Hepatitis c virus tunic protein E2 gene capable of being total length expressed in E. coli, its coding protein and use |
| 01/07/2004 | CN1465698A Phytase APPB and DNA for coding same |
| 01/07/2004 | CN1465696A Polypeptide-trorsine 14 and polynucleotide for coding said polypeptide |
| 01/07/2004 | CN1465597A Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition |
| 01/07/2004 | CN1465594A Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |
| 01/07/2004 | CN1465593A Mouse interleukin-17 receptor sample protein, and coding gene and use thereof |